Talcum Powder Litigation Report

Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.



Current Issue

J&J Seeks Transfer of Multi-Billion Talc Verdict Appeal to Mo. Supreme Court

Johnson & Johnson and Johnson & Johnson Consumer Inc. have asked a Missouri appellate court to transfer the appeal of a multi-billion talcum powder verdict to the state’s highest court, arguing that an intermediate appellate court opinion affirming the verdict conflicts with the opinions of other Missouri appellate courts.

J&J Seeks Appointment of Independent Expert Witness to Help Aid Jurors with ‘Complicated Scientific Questions’; Plaintiffs Oppose Efforts

Johnson & Johnson defendants have asked the federal court overseeing the national multidistrict litigation docket for talcum powder personal injury claims to appoint an independent expert witness in the areas of epidemiology and cancer biology, saying that doing so will “assist jurors in better understanding scientific issues.”

Fla. State Court to Oversee Hearing on Sufficiency of Asbestos-Talc Lawsuit

A Florida state court is set to oversee arguments relating to Johnson & Johnson’s motion to dismiss an asbestos-talcum powder lawsuit, in which the defendant maintains that the plaintiff has failed to set forth sufficient facts in the complaint.

Fla. State Court to Hold Hearing on Defense Efforts to Continue Trial Date in Asbestos Talc Case

A Florida state court is set to hold a hearing on a motion for entry of a modified scheduling order, where it will address a request by the defendants in an asbestos-talc personal injury action to continue the current trial date to November.

Fla. State Court Sets Talcum Powder Ovarian Cancer Case for Early 2021 Trial

A Florida state court has issued an order setting a jury trial in a talcum powder ovarian cancer personal injury case, saying that a jury trial will take place in the first two months of 2021.

N.J. Court Reverses Order Dismissing Talcum Powder Ovarian Cancer Claims, Says Lower Court ‘Chose Between’ Experts

Four years after they were dismissed, two talcum powder ovarian cancer cases have been reinstated by a New Jersey appellate court, which concluded that, in tossing the claims, the trial court had “chose between plaintiffs’ and defendants’ experts based on his assessment of the credibility of their opinions.”

Missouri Appellate Court Denies Motions to Review Order Affirming Multi-Billion Talc Verdict

A Missouri appellate court has denied Johnson & Johnson and Johnson & Johnson Consumer Inc.’s motion for rehearing, rejecting the defendants’ efforts to revisit an order affirming a multi-billion talcum powder verdict in part.

Issue #44, July 2020

BASF and Longtime National Counsel to Pay $72.5 Million to Settle Asbestos-Talc Fraud Claims

BASF Catalysts LLC, and its longtime national counsel, will establish a $72.5 million settlement fund to compensate those plaintiffs in a settlement class who contended in prior lawsuits that they have been harmed by asbestos-containing talc produced by a company acquired by BASF, according to a recent motion for approval.

Parties in Calif. Coordinated Talcum Powder Docket Agree to Extend Trial-Related Deadlines

The parties in the California coordinated docket for state talcum powder personal injury claims have reached an agreement to extend the deadline by which the cases filed before January 2018 must be brought to trial.

J&J Defendants Seek Review of Order Affirming Multi-Billion Talc Verdict by Mo. Supreme Court

Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed a motion for rehearing and an application for transfer to the Missouri Supreme Court in the wake of an intermediate appellate court decision affirming a multi-billion talcum powder verdict in part.

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.